en

PRODUCT DETAIL

Fulvestrant Accord 250 mg injekčný roztok naplnený v injekčnej striekačke

Code 0761D
MA number 34/0069/19-S
Product Form: sol iru 2x250 mg/5 ml (striek.inj.napl.+2 ihly)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 34 - ANTIHORMONA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BA03 Fulvestrant
Shelf life: 24
Container: pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 11.03.2019
Pediatric warnings: Yes
SPC: SPC_Fulvestrant Accord_06_2021.pdf  
PIL: PIL_Fulvestrant Accord_11_2022.pdf  
Safety feature Yes
Data update: 21.12.2022
eu-flag.png sk-flag.png